Who is sponsoring NCT06000527?

NCT06000527 is sponsored by Imagine Institute.

What condition does NCT06000527 study?

NCT06000527 studies Juvenile Recurrent Respiratory Papillomatosis.

Is NCT06000527 still recruiting?

NCT06000527 is currently recruiting now. Last updated 21 August 2023.

Last reviewed 2023-08-21 · How we verify

NCT06000527: REPA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")

Recruiting now Last updated 21 August 2023

What this trial tests

trial in Juvenile Recurrent Respiratory Papillomatosis in 200 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
30 September 2032

30 September 2032

Quick facts

Lead sponsor	Imagine Institute
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 October 2022
Primary completion	30 September 2032
Estimated completion	30 September 2032
Sites	1 location across France

Conditions studied

Juvenile Recurrent Respiratory Papillomatosis — all drugs for Juvenile Recurrent Respiratory Papillomatosis →

Sponsor

Imagine Institute

Who can join

Eligibility, any sex, with Juvenile Recurrent Respiratory Papillomatosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Imagine Institute trials

Trials by the same sponsor.

NCT07313098 — Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvemen · not yet recruiting
NCT07422454 — FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects · recruiting
NCT06219421 — Automatic Phenotyping of Patients on 2D Photography · recruiting
NCT06186856 — Epidemiological Data on Mast Cell Pathologies in France · recruiting
NCT06380192 — Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06000527 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imagine Institute
Last refreshed: 21 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing